Inaugurating Dharna at Jantar Mantar Delhi by Anglo-Indian Joint Action Group

 

The photo taken shows Archbishop of Delhi Dr. Anil Couto inaugurating the  Dharna at Jantar Mantar Delhi by Anglo-Indian Joint Action Group on 9th October 2022.


Comments

Post a Comment

Popular posts from this blog

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

Image
  Bharat Petroleum Corporation Limited (BPCL) dealer network has rolled out its festive season campaign, “Fuelling the Festive Spirit”, from 22nd September to 31st October 2025 across 3,000 Retail Outlets in Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu.   Customers fuelling up with eligible transactions can win exciting prizes of 17 car and  83 Bikes through QR-based digital  slogan context participation. BPCL spokesperson said, “Festivals in India are a time of joy, giving, and togetherness. With ‘Fuelling the Festive Spirit,’ we are delighted to reward our customers and empower our frontline teams, making every visit to our retail outlets during this festive season truly memorable.”
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Gleneagles Hospital Successfully Treats Rare CNS (Brain) Lymphoma with Advanced CAR-T Cell Therapy

Image
Gleneagles Hospital Chennai, a part of Fortis Healthcare, has successfully treated a 49-year-old patient from Andhra Pradesh diagnosed with a rare and aggressive form of CNS(brain) lymphoma using advanced CAR-T cell therapy. Despite developing multiple serious treatment-related complications, the patient achieved complete remission and is doing well. The patient presented with complaints of persistent headache, giddiness, difficulty in walking, and weakness in his left arm and leg. Detailed investigations confirmed Primary Central Nervous System Lymphoma (PCNSL) , a rare type of lymphoma that affects the brain and is known to be difficult to treat. The patient initially received high-dose chemotherapy, the standard first-line treatment for this condition. However, the disease continued to progress despite four cycles of treatment. He subsequently underwent radiotherapy with chemotherapy, followed by oral targeted therapy as bridging treatment. As the lymphoma remained resistant to ...
Read more